Japara Healthcare (JHC.AX) Stock Price

Japara Healthcare Price

Delisted

Revenue has compounded at 7.3% per year over the past 9 years to 419.54 M AUD. Earnings per share have declined at 13.4% per year over the last 4 years. Japara Healthcare's net margin stands at -3.4%, down from 8.4% several years earlier.

Japara Healthcare stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Japara Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Japara Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Japara Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Japara Healthcare Stock Price History
DateJapara Healthcare Price
Access this data via the Eulerpool API

Japara Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
394.94 M AUD
24.73 M AUD
16.43 M AUD
Jan 1, 2020
422.24 M AUD
1.14 M AUD
-292.09 M AUD
Jan 1, 2021
419.54 M AUD
-29.05 M AUD
-14.11 M AUD
Jan 1, 2022 (e)
471.85 M AUD
0.00 AUD
1.82 M AUD
Jan 1, 2023 (e)
492.75 M AUD
0.00 AUD
7.08 M AUD
Jan 1, 2024 (e)
511.88 M AUD
0.00 AUD
10.98 M AUD
Jan 1, 2025 (e)
517.34 M AUD
0.00 AUD
27.19 M AUD
Jan 1, 2026 (e)
519.49 M AUD
0.00 AUD
67.97 M AUD

Japara Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 13, 2026, 6:41 AM
 
REVENUEM AUD
REVENUE GROWTH%
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
20122013201420152016201720182019202020212022e2023e2024e2025e2026e
221.00229.0048.00278.00325.00353.00361.00394.00422.00419.00471.00492.00511.00517.00519.00
3.62-79.04479.1716.918.622.279.147.11-0.7112.414.463.861.170.39
36.0033.0038.0043.0037.0021.0024.001.00-29.00
16.2914.4113.6713.2310.485.826.090.24-6.92
-2.0028.0030.0029.0023.0016.00-292.00-14.001.007.0010.0027.0067.00
-1,500.007.14-3.33-20.69-30.43-1,925.00-95.21-107.14600.0042.86170.00148.15
262.50262.50262.50263.64263.81265.85266.35266.74266.82267.14267.14267.14267.14267.14267.14
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Japara Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Japara Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Japara Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Japara Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Japara Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Japara Healthcare stock margins

The Japara Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Japara Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Japara Healthcare.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
0.00 %
10.65 %
8.39 %
Jan 1, 2018
0.00 %
6.04 %
6.45 %
Jan 1, 2019
0.00 %
6.26 %
4.16 %
Jan 1, 2020
0.00 %
0.27 %
-69.18 %
Jan 1, 2021
0.00 %
-6.92 %
-3.36 %
Jan 1, 2022 (e)
0.00 %
0.00 %
0.39 %
Jan 1, 2023 (e)
0.00 %
0.00 %
1.44 %
Jan 1, 2024 (e)
0.00 %
0.00 %
2.15 %

Japara Healthcare Stock Revenue, EBIT, Earnings per Share

The Japara Healthcare earnings per share therefore indicates how much revenue Japara Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
1.33 AUD
0.14 AUD
0.11 AUD
Jan 1, 2018
1.36 AUD
0.08 AUD
0.09 AUD
Jan 1, 2019
1.48 AUD
0.09 AUD
0.06 AUD
Jan 1, 2020
1.58 AUD
0.00 AUD
-1.09 AUD
Jan 1, 2021
1.57 AUD
-0.11 AUD
-0.05 AUD
Jan 1, 2022 (e)
1.77 AUD
0.00 AUD
0.01 AUD
Jan 1, 2023 (e)
1.85 AUD
0.00 AUD
0.03 AUD
Jan 1, 2024 (e)
1.92 AUD
0.00 AUD
0.04 AUD

Japara Healthcare business model & stock analysis

Japara Healthcare Ltd is an Australian company specializing in providing care and support services for older people, as well as accommodations and programs for seniors.

Japara Healthcare SWOT Analysis

Strengths

1. Market Leader

Japara Healthcare Ltd is one of the leading healthcare companies in the market, with a strong presence and a large customer base. This gives them a competitive advantage in terms of market share and brand recognition.

2. Diverse Service Offering

The company offers a wide range of healthcare services, including aged care facilities, retirement living, home care, and respite care. This diversity in service offering allows Japara Healthcare to cater to different customer needs and preferences, ensuring a steady revenue stream.

3. Strong Financial Performance

Japara Healthcare has consistently delivered strong financial results, with a track record of revenue growth and profitability. This financial stability provides the company with the resources needed for expansion, investments in new facilities, and improved service quality.

Weaknesses

1. Dependence on Government Funding

A significant portion of Japara Healthcare's revenue comes from government funding, which makes the company vulnerable to changes in government policies or funding cuts. This reliance on external sources of revenue exposes them to potential risks.

2. Aging Infrastructure

Some of Japara Healthcare's facilities are older and may require substantial investments in renovation and upgrading. Outdated infrastructure can negatively impact the quality of care and the attractiveness of their facilities, potentially leading to a loss of market share.

3. Limited Geographic Presence

Although Japara Healthcare operates nationally in Australia, their geographical presence is limited compared to some competitors. This restricts their market reach and growth potential in certain regions, potentially allowing competitors to gain an advantage in those areas.

Opportunities

1. Aging Population

The aging population in Australia presents a significant opportunity for Japara Healthcare. With an increasing demand for aged care services, the company can expand its customer base and generate more revenue by targeting this growing segment of the population.

2. Technological Advancements

Advancements in healthcare technology, such as remote patient monitoring and telehealth services, present opportunities for Japara Healthcare to improve the efficiency and effectiveness of its healthcare delivery. Embracing these technologies can enhance customer experience and attract more tech-savvy individuals.

3. Strategic Partnerships

Collaborating with other healthcare providers, medical professionals, or technology companies can offer Japara Healthcare access to new expertise, resources, and markets. Strategic partnerships can enable them to diversify their service offerings, expand geographically, and enhance their competitive position.

Threats

1. Regulatory Environment

Changes in government regulations and compliance requirements within the healthcare industry can pose challenges for Japara Healthcare. Adapting to new regulations, ensuring compliance, and managing associated costs can be demanding and impact profitability.

2. Competition

The healthcare industry is highly competitive, with both existing and new players vying for market share. Increased competition can lead to pricing pressures, reduced margins, and the need for continuous innovation to stay ahead.

3. COVID-19 Pandemic

The ongoing COVID-19 pandemic has had a significant impact on the healthcare industry, including aged care providers like Japara Healthcare. The pandemic introduced risks such as outbreaks within facilities, increased costs for personal protective equipment (PPE), and decreased occupancy rates due to reduced admissions.

Japara Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Japara Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Japara Healthcare annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Japara Healthcare shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
265.85 M Stocks
Jan 1, 2018
266.35 M Stocks
Jan 1, 2019
266.74 M Stocks
Jan 1, 2020
266.82 M Stocks
Jan 1, 2021
267.14 M Stocks
Jan 1, 2022 (e)
267.14 M Stocks
Jan 1, 2023 (e)
267.14 M Stocks
Jan 1, 2024 (e)
267.14 M Stocks

Japara Healthcare Dividend History

6 years of dividend payments

YearAnnual DividendYoY ChangePayments
20200.02AUD 64.6%
20190.07AUD 29.0%
20180.10AUD 36.9%
20170.15AUD 6.7%
20160.16AUD 23.0%
20150.13AUD

Japara Healthcare dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
137.19 %
Jan 1, 2018
110.39 %
Jan 1, 2019
111.48 %
Jan 1, 2020
-2.22 %
Jan 1, 2021
119.68 %
Jan 1, 2022 (e)
113.85 %
Jan 1, 2023 (e)
115.00 %
Jan 1, 2024 (e)
116.18 %
Price targets and forecasts for Japara Healthcare are not yet available.

Japara Healthcare Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
2/24/2021-0.02AUD-235.48 MAUD-2021 Q2
8/26/20200.01AUD-224.31 MAUD-2020 Q4
2/28/20200.02AUD-216.19 MAUD-2020 Q2
8/26/20190.04AUD-208.07 MAUD-2019 Q4
2/25/20190.03AUD--AUD-2019 Q2
8/27/2018-AUD-286.23 MAUD-2018 Q4

Japara Healthcare shareholder structure

% Name
9.23561%
Aurrum Holdings Pty. Ltd.
Aurrum Holdings Pty. Ltd.
2.82114%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
1.96997%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.29397%
GAM Capital Management (Switzerland) AG
GAM Capital Management (Switzerland) AG
0.14082%
Charles Schwab Investment Management, Inc.
Charles Schwab Investment Management, Inc.
0.10364%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.

Japara Healthcare Supply Chain

Japara Healthcare Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
5 companies
#NameTrend
1
Perpetual
Supplier·Customer·Capital Markets·AU
0.67
0.44
-0.48
-0.40
-0.81
2
Citigroup
Supplier·Customer·Banks·US
0.15
-0.17
-0.45
-0.59
-0.80
3
HSBC Holdings
Supplier·Customer·Banks·GB
0.09
-0.30
0.02
0.74
0.84
4
JPMorgan Chase
Supplier·Customer·Banks·US
0.04
-0.62
-0.38
-0.72
-0.58
5
MA Financial Group
Supplier·Customer·Capital Markets·AU
-0.75
-0.74
-0.41
-0.61
0.63

Frequently asked questions about Japara Healthcare

Japara Healthcare Ltd operates in the healthcare industry and is primarily involved in the provision of residential aged care services. The company offers various services including permanent residency, respite care, and specialist dementia care. Japara Healthcare aims to provide high-quality, person-centered care to meet the individual needs of each resident. With a focus on delivering superior healthcare services, Japara Healthcare Ltd strives to enhance the well-being and quality of life for the elderly in Australia through its extensive portfolio of aged care facilities.

Japara Healthcare Ltd is primarily active in the healthcare and aged care industries.

Some of the main competitors of Japara Healthcare Ltd in the market include Regis Healthcare Limited, Estia Health Limited, and Ramsay Health Care Limited.

Japara Healthcare Ltd is an Australian company specializing in the provision of quality aged care services. Established in 2005, Japara has rapidly grown to become a trusted leader in the sector. With a strong focus on person-centered care, Japara operates a network of residential aged care facilities across Australia, offering a comprehensive range of services tailored to meet the individual needs of their residents. Additionally, the company actively supports and invests in innovative healthcare practices, ensuring the delivery of exceptional care outcomes. Japara Healthcare Ltd prides itself on its commitment to enhancing the quality of life for older Australians through compassionate and professional care.

Japara Healthcare Ltd has achieved several significant milestones in its operational journey. The company successfully extended its aged care portfolio by acquiring additional residential facilities, enabling it to serve a larger customer base. Japara Healthcare has also taken strategic initiatives to enhance its service quality, including the implementation of innovative health programs and advanced technology solutions. The company's commitment to employee development and training has led to the recognition of Japara Healthcare as an industry leader in providing high-quality care services. Furthermore, Japara Healthcare's focus on continuous improvement contributed to the achievement of various industry accolades, reaffirming its position as a trusted and reliable provider in the healthcare sector.

Japara Healthcare Ltd is primarily present in Australia.

Japara Healthcare Ltd represents values of compassion, integrity, and excellence in providing aged care services. The company's corporate philosophy centers on the belief that every individual deserves to be treated with dignity and respect, ensuring the highest quality of care for seniors. Japara Healthcare is committed to fostering a safe and supportive environment, promoting independence, and maintaining strong relationships with residents and their families. Through their extensive experience and expertise in the industry, Japara Healthcare upholds their mission of enriching lives and delivering exceptional aged care solutions.

The Japara Healthcare share (JHC.AX) is listed on 1 stock exchanges, including: ASX (JHC.AX).

Japara Healthcare Ltd is a leading Australian provider of care services. The company offers a comprehensive range of services, including nursing homes, assisted living, home nursing, rehabilitation, and specialty care. The nursing homes provide residents with a safe and comfortable environment with a diverse range of activities and programs. The assisted living offering includes all necessary support services to help seniors lead independent lives, with experienced and trained staff catering to their needs. Japara Healthcare also offers home nursing to assist older people who would otherwise need to live in a nursing home, providing services such as daily routine assistance, medication management, and support for physical and mental activity. In addition to these core business areas, Japara Healthcare provides specialized care services, including rehabilitation and palliative care, to help patients cope with specific health issues. The company utilizes cutting-edge technology to simplify patient information management and support care staff, while its "One-Stop-Shop" model enables it to offer all necessary health services under one roof. Through the integration of telemedicine technologies, Japara Healthcare ensures even better care for its patients. Its business model allows the company to play a leading role in the Australian healthcare services market, effectively meeting the needs of its patients by offering a comprehensive range of healthcare services. Additionally, Japara Healthcare provides training and education courses for patient care, constantly improving the skills of its employees and providing them with the best tools and resources to optimize care quality. Ultimately, the business model aims to improve the lives of older people in Australia by providing them with high-quality healthcare and support when needed. By combining top-notch facilities, experienced and dedicated staff, and state-of-the-art technology, Japara Healthcare is able to create true value for its customers and establish itself as a leading provider of healthcare and care services.

The revenue cannot currently be calculated for Japara Healthcare.

The profit cannot currently be calculated for Japara Healthcare.

The P/E ratio cannot be calculated for Japara Healthcare at the moment.

The P/S cannot be calculated for Japara Healthcare currently.

The Eulerpool Quality Score for Japara Healthcare is 2/10.

The ISIN of Japara Healthcare is AU000000JHC5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Japara Healthcare is A111Q7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Japara Healthcare is JHC.AX. The ticker symbol is used to trade Japara Healthcare shares on the stock exchange.

The current dividend yield of Japara Healthcare is - %.

Japara Healthcare is assigned to the 'Health' sector.

The dividends of Japara Healthcare are distributed in AUD.

All fundamentals and in-depth analysis of Japara Healthcare

Our stock analysis for Japara Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Japara Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.